Experience

Davis Polk is representing J.P. Morgan in a state securities fraud litigation pending in Florida state court. On Friday, June 9, 2017, we won a complete reversal of the trial court’s grant…

On November 3, 2016, the Second Circuit issued an opinion in an action brought under Section 16(b) of the Exchange Act of 1934 against Morgan Stanley, J.P. Morgan and Goldman Sachs, the…

Davis Polk represents several current and former directors of Orexigen Therapeutics (the “Company”) in connection with derivative litigation relating to the award of equity compensation. On…

Davis Polk achieved a major victory on behalf of Morgan Stanley and certain of its officers and directors in a Section 10(b) shareholder class action arising from Morgan Stanley’s 2007…

Davis Polk achieved a major victory on behalf of Morgan Stanley and certain of its officers and directors in two Employee Retirement Income Security Act of 1974 (“ERISA”) class actions…